Breast Cancer Prognosis No Better With Five Versus Two Years of Zoledronate

No significant difference found in disease - free survival, overall survival, distant disease - free survival for five versus two years of treatment
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Journal, Source Type: news